University of Colorado Hospital, Anschutz Outpatient Pavilioin — Aurora, Colorado

University of Colorado Hospital, Anschutz Outpatient Pavilioin is a clinical research site located in Aurora, Colorado, United States.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Colorado Hospital, Anschutz Outpatient Pavilioin has participated in 1 clinical trials.

Therapeutic areas: Multiple Sclerosis, Relapsing-Remitting.

Sponsors: Genzyme, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Aurora

Browse all research sites in Colorado · View every site in Aurora

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Colorado Hospital, Anschutz Outpatient Pavilioin?

University of Colorado Hospital, Anschutz Outpatient Pavilioin has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Colorado Hospital, Anschutz Outpatient Pavilioin conducted?

University of Colorado Hospital, Anschutz Outpatient Pavilioin has 1 clinical trials on record. Their work covers Multiple Sclerosis, Relapsing-Remitting.

Is University of Colorado Hospital, Anschutz Outpatient Pavilioin accredited by Crixeo Clinical Trials?

University of Colorado Hospital, Anschutz Outpatient Pavilioin has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Colorado Hospital, Anschutz Outpatient Pavilioin?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.